Literature DB >> 8457055

Effects of propofol and thiopental on maternal and fetal cardiovascular and acid-base variables in the pregnant ewe.

E Alon1, R H Ball, M H Gillie, J T Parer, M A Rosen, S M Shnider.   

Abstract

BACKGROUND: The effects of propofol on uterine blood flow are not understood well. This is a relatively new agent that is finding increased use for nonobstetric surgical procedures during pregnancy and induction of anesthesia for cesarean section.
METHODS: The effects of induction and maintenance of anesthesia with propofol were studied on maternal and fetal cardiovascular and acid-base variables in a chronically instrumented pregnant sheep model. Anesthesia was induced with a 2 mg/kg bolus of propofol and maintained with of one of three continuous infusions: 150, 300, and 450 micrograms.kg-1 x min-1. The control group received thiopental for induction, and anesthesia was maintained with isoflurane.
RESULTS: The use of propofol did not adversely affect maternal or fetal mean arterial pressure, heart rate, or base excess, fetal heart rate variability, or uterine blood flow. Uterine blood flow transiently decreased during induction and intubation with thiopental but remained stable during induction with propofol. However, administration of succinylcholine for intubation in the presence of propofol resulted in a transient, but severe, maternal bradycardia. Continuous infusion of 300 micrograms.kg-1.min-1 of propofol appeared to provide satisfactory anesthesia in the ewe.
CONCLUSIONS: Assuming the applicability of ovine data to humans, these findings suggest that induction and maintenance of anesthesia with propofol and 50% nitrous oxide in oxygen has no adverse fetal effects but warrants caution because of the potential risk of severe maternal bradycardia during induction of anesthesia using the combination of propofol and succinylcholine.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8457055     DOI: 10.1097/00000542-199303000-00020

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  8 in total

1.  Effects of propofol on gravid human uterine muscle.

Authors:  Tat-Leang Lee; P Ganesan Adaikan; Lang Chu Lau; Ashok Kumar; Shan S Ratnam
Journal:  J Anesth       Date:  1997-03       Impact factor: 2.078

Review 2.  Pharmacokinetic optimisation of general anaesthesia in pregnancy.

Authors:  T Gin
Journal:  Clin Pharmacokinet       Date:  1993-07       Impact factor: 6.447

3.  Utilization of optimal study design for maternal and fetal sheep propofol pharmacokinetics study: a preliminary study.

Authors:  Catherine M T Sherwin; Pornswan Ngamprasertwong; Senthilkumar Sadhasivam; Alexander A Vinks
Journal:  Curr Clin Pharmacol       Date:  2014-02

Review 4.  Update in fetal anesthesia for the ex utero intrapartum treatment (EXIT) procedure.

Authors:  Pornswan Ngamprasertwong; Alexander A Vinks; Anne Boat
Journal:  Int Anesthesiol Clin       Date:  2012

Review 5.  Propofol. An update of its use in anaesthesia and conscious sedation.

Authors:  H M Bryson; B R Fulton; D Faulds
Journal:  Drugs       Date:  1995-09       Impact factor: 9.546

6.  Leg cramps in pregnancy caused by chronic compartment syndrome and relieved by fasciotomy after childbirth.

Authors:  Jan Roar Orlin; Jarle Oen; John Roger Andersen; Ivar Jostein Tjugum; Hans Jacob Westbye; Jomar Roska; Helene Aasved; Kjersti Hjelmeland
Journal:  Clin Case Rep       Date:  2014-05-05

7.  Perioperative management of emergent cesarean section in a patient with peripartum cardiomyopathy and orthopnea: a case report.

Authors:  Yuko Kawamoto; Tasuku Nishihara; Jun Aono; Hideyuki Nandate; Taisuke Hamada; Toshiaki Yasuoka; Takashi Matsumoto; Osamu Yamaguchi; Takashi Sugiyama; Toshihiro Yorozuya
Journal:  J Int Med Res       Date:  2021-12       Impact factor: 1.671

8.  Sedation with Propofol plus Paracetamol in External Cephalic Version: An Observational Study.

Authors:  Javier Sánchez-Romero; Jesús López-Pérez; Ana Belén Flores-Muñoz; María Josefa Méndez-Martínez; Fernando Araico-Rodríguez; Jaime Mendiola-Olivares; José Eliseo Blanco-Carnero; Luis Falcón-Araña; Aníbal Nieto-Díaz; María Luisa Sánchez-Ferrer
Journal:  J Clin Med       Date:  2022-01-19       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.